300463 Maccura Biotechnology
- 11.74
- -0.01-0.09%
Maccura Biotechnology News
Mike Biotech: Progress Announcement on the Use of Some Idle Raised Funds for Cash Management
Mike Biotech: Announcement on obtaining product registration certificates for new products of the company and its wholly-owned subsidiaries
Mike Biotech: Progress announcement on the repurchase of the company\'s shares
Mike Biotech: Announcement on the completion of cancellation of some special fund-raising accounts
Mike Biotech: Progress Announcement on the Use of Some Idle Raised Funds for Cash Management
Mike Biotech: Announcement on obtaining a product registration certificate for the company\'s new products
Maccura Biotechnology: Announcement regarding the company's new product obtaining a product registration certificate.
Maccura Biotechnology: Announcement regarding the company's product obtaining IVDR CE certification.
Maccura Biotechnology: Announcement on the completion of the cancellation of certain special-purpose account for raised funds.
Maccura Biotechnology: China Merchants Securities Co., Ltd.'s continuous supervision and follow-up report on Maccura Biotechnology Co., Ltd.'s 2024 half-yearly period.
Maccura Biotechnology: Announcement regarding the company's new product obtaining a product registration certificate.
Maccura Biotechnology: 300463 MACCURA BIOTECH Investor Relations Management Information 20240802
Maccura Biotechnology: Announcement regarding the progress of repurchasing company shares.
Maccura Biotechnology: Half-year report for the year 2024.
Maccura Biotechnology: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Maccura Biotechnology: Announcement of the resolution of the 18th meeting of the 5th board of directors.
Maccura Biotechnology: Announcement of the resolution of the 16th meeting of the 5th Board of Supervisors.
Maccura Biotechnology: Announcement on disclosure of the 2024 interim report
Maccura Biotechnology: Special report on the use and placement of funds raised during the first half of 2024.
Maccura Biotechnology: Summary of Half-Year Report in 2024.
Analysis
Price Target
No Data
